CD147 is a regulatory subunit of the γ-secretase complex in Alzheimer's disease amyloid β-peptide production
- Life Sciences Division, Lawrence Berkeley National Laboratory, University of California, Berkeley, CA 94720
-
Communicated by Pamela J. Bjorkman, California Institute of Technology, Pasadena, CA, April 5, 2005 (received for review December 27, 2004)
Abstract
γ-Secretase is a membrane protein complex that cleaves the β-amyloid precursor protein (APP) within the transmembrane region, after prior processing by β-secretase, producing amyloid β-peptides Aβ40 and Aβ42. Errant production of Aβ-peptides that substantially increases Aβ42 production has been associated with the formation of amyloid plaques in Alzheimer's disease patients. Biophysical and genetic studies indicate that presenilin-1, which contains the proteolytic active site, and three other membrane proteins [nicastrin, anterior pharynx defective-1 (APH-1), and presenilin enhancer-2 (PEN-2)] are required to form the core of the active γ-secretase complex. Here, we report the purification of the native γ-secretase complexes from HeLa cell membranes and the identification of an additional γ-secretase complex subunit, CD147, a transmembrane glycoprotein with two Ig-like domains. The presence of this subunit as an integral part of the complex itself was confirmed through coimmunoprecipitation studies of the purified protein from HeLa cells and of solubilized complexes from other cell lines such as neural cell HCN-1A and HEK293. Depletion of CD147 by RNA interference was found to increase the production of Aβ peptides without changing the expression level of the other γ-secretase components or APP substrates whereas CD147 overexpression had no statistically significant effect on Aβ-peptide production, other γ-secretase components or APP substrates, indicating that the presence of the CD147 subunit within the γ-secretase complex down-modulates the production of Aβ-peptides.
Footnotes
-
↵ * To whom correspondence should be addressed at: Lawrence Berkeley National Laboratory, Mail Stop: Donner, 1 Cyclotron Road, Berkeley, CA 94720. E-mail: bkjap{at}lbl.gov.
-
Author contributions: S.Z., H.Z., P.J.W., and B.K.J. designed research, performed research, analyzed data, and wrote the paper.
-
Abbreviations: AD, Alzheimer's disease; APP, β-amyloid precursor protein; Aβ, amyloid β; Psn-1, presenilin-1; NTF, N-terminal fragment; CTF, C-terminal fragment; Nct, nicastrin; APH-1, anterior pharynx defective-1; PEN-2, presenilin enhancer-2; siRNA, small interfering RNA; RNAi, RNA interference.
-
Freely available online through the PNAS open access option.
- Copyright © 2005, The National Academy of Sciences





